CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-24 | Taylor Stacy L SVP and General Counsel | Sale | −2,880 | $36.03 | $104K | 1,300 |
| 2020-07-24 | Taylor Stacy L SVP and General Counsel | Option exercise · Stock Option (Right to Buy) | −1,109 | 38,363 | ||
| 2020-07-24 | Taylor Stacy L SVP and General Counsel | Option exercise · Stock Option (Right to Buy) | −1,771 | 35,417 | ||
| 2020-07-20 | GOEL DAVID E. Director | Sale | −2,000,000 | $40.00 | $80.0M | 13,115,090 |
| 2020-07-20 | BENZENO SHARON Chief Business Development Off | Option exercise | +417 | $6.27 | $3K | 417 |
| 2020-07-20 | BENZENO SHARON Chief Business Development Off | Sale | −417 | $40.00 | $17K | 0 |
| 2020-07-20 | BENZENO SHARON Chief Business Development Off | Option exercise · Stock Option (Right to Buy) | −417 | 3,750 | ||
| 2020-07-17 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +11,100 | $6.32 | $70K | 11,779 |
| 2020-07-17 | ROBINS HARLAN S Chief Scientific Officer | Sale | −1,200 | $38.61 | $46K | 10,579 |
| 2020-07-17 | ROBINS HARLAN S Chief Scientific Officer | Sale | −8,194 | $39.62 | $325K | 2,385 |
| 2020-07-17 | ROBINS HARLAN S Chief Scientific Officer | Sale | −1,706 | $40.23 | $69K | 679 |
| 2020-07-17 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,100 | 366,900 | ||
| 2020-07-16 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +22,200 | $6.32 | $140K | 22,879 |
| 2020-07-16 | ROBINS HARLAN S Chief Scientific Officer | Sale | −14,820 | $39.39 | $584K | 8,059 |
| 2020-07-16 | ROBINS HARLAN S Chief Scientific Officer | Sale | −7,380 | $39.92 | $295K | 679 |
| 2020-07-16 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −22,200 | 378,000 | ||
| 2020-07-15 | LO FRANCIS Chief People Officer | Option exercise | +2,000 | $7.80 | $16K | 2,000 |
| 2020-07-15 | LO FRANCIS Chief People Officer | Sale | −1,500 | $43.62 | $65K | 500 |
| 2020-07-15 | LO FRANCIS Chief People Officer | Sale | −500 | $44.56 | $22K | 0 |
| 2020-07-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (Right To Buy) | −2,000 | 196,000 |
Page 97 of 120 · 2,386 trades